Novel albumin-binding agents for FAP-targeted radionuclide therapy presented Oct. 18, 2019 No Comments
Synthesis and characterization of novel N-carboxymethyl-substituted PSMA ligands Oct. 18, 2019 No Comments
18F-Labeled PSMA ligand development leads to clinical candidate [18F]siPSMA-14 Oct. 18, 2019 No Comments
[68Ga]Ga-DO3A-S01-GCG: a first-in-class GCGR PET tracer with proof of concept in preclinical phase Oct. 17, 2019 No Comments
In vitro and in vivo characterization of [177Lu]DOTA-G-02113 and [68Ga]DOTA-G-02113 presented Oct. 17, 2019 No Comments
Weak albumin-binding PSMA radioligands for improved prostate cancer therapy Oct. 16, 2019 No Comments
Novel PSMA-targeting 177-Lu radiolabeled compounds with outstanding tumor uptake presented Oct. 15, 2019 No Comments
RSS